Specify a stock or a cryptocurrency in the search bar to get a summary
Tianjin Tianyao Pharmaceuticals Co Ltd
600488Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. Its primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as dosage forms, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It also exports its products to the United States, Southeast Asia, Europe, South America, Africa, and internationally. The company was founded in 1999 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd. Address: No. 19, Xinye Ninth Street, Tianjin, China, 300462
Analytics
WallStreet Target Price
40.48 CNYP/E ratio
31.7857Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600488
Dividend Analytics 600488
Dividend growth over 5 years
-72 %Continuous growth
–Payout Ratio 5 years average
49 %Dividend History 600488
Stock Valuation 600488
Financials 600488
Results | 2019 | Dynamics |